Correlation Between XBiotech and Enveric Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both XBiotech and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XBiotech and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XBiotech and Enveric Biosciences, you can compare the effects of market volatilities on XBiotech and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XBiotech with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of XBiotech and Enveric Biosciences.

Diversification Opportunities for XBiotech and Enveric Biosciences

0.22
  Correlation Coefficient

Modest diversification

The @@bw1eo months correlation between XBiotech and Enveric is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding XBiotech and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and XBiotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XBiotech are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of XBiotech i.e., XBiotech and Enveric Biosciences go up and down completely randomly.

Pair Corralation between XBiotech and Enveric Biosciences

Given the investment horizon of 90 days XBiotech is expected to generate 0.4 times more return on investment than Enveric Biosciences. However, XBiotech is 2.51 times less risky than Enveric Biosciences. It trades about 0.1 of its potential returns per unit of risk. Enveric Biosciences is currently generating about 0.02 per unit of risk. If you would invest  328.00  in XBiotech on February 3, 2024 and sell it today you would earn a total of  521.00  from holding XBiotech or generate 158.84% return on investment over 90 days.
Time Period@@bw1EO Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

XBiotech  vs.  Enveric Biosciences

 Performance 
       Timeline  
XBiotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in XBiotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating forward indicators, XBiotech unveiled solid returns over the last few months and may actually be approaching a breakup point.
Enveric Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days Enveric Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Enveric Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

XBiotech and Enveric Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with XBiotech and Enveric Biosciences

The main advantage of trading using opposite XBiotech and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XBiotech position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.
The idea behind XBiotech and Enveric Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years